Balestra et al. identified antibodies against α7- and α3-nAChRs in 5 of 60 patients with MG, suggesting a potential association with various clinical features, including autonomic symptoms (Balestra et al., 2000). Here, CHRNA4 is linked to myasthenia gravis.